Powered by
DETROIT–Officials at the Barbara Ann Karmanos Cancer Institute announced the adoption of Volpara Risk Pathways, software designed to simplify risk assessment and patient management for various cancers, including breast, lung, …
DETROIT—The Barbara Ann Karmanos Cancer Institute recently received a $352,437 grant from the U CAN-CER VIVE Foundation to help fund a pancreatic cancer research study. The outcomes of this study will help …
NOVI—Officials at Delphinus Medical Technologies Inc. announced that the U.S. Food and Drug Administration has granted premarket approval of its SoftVue 3D Whole Breast Ultrasound Tomography System. The system is …
DETROIT—The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) launched new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and …
DETROIT—Officials at the Barbara Ann Karmanos Cancer Institute announced that its National Cancer Institute (NCI) Core Grant has been renewed. This renewal extends Karmanos’ prestigious NCI designation through 2025, making …
DETROIT—An oral therapy that has been studied in laboratory experiments and clinical trials at the Barbara Ann Karmanos Cancer Institute, in partnership with Karyopharm Therapeutics Inc., will soon enter clinical …